Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.13+0.05 (+1.62%)
Close on Nov 18, 2026Market cap $178.44MP/E –Yield –
Whitehawk Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Whitehawk Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$69.35M. For fiscal 2025 it was -$97.43M. The highest annual figure on record is -$16.02K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$97.43M | – |
| FY2024 | Dec 31, 2024 | -$59.55M | – |
| FY2023 | Dec 31, 2023 | -$59.66M | – |
| FY2022 | Dec 31, 2022 | -$49.64M | – |
| FY2021 | Dec 31, 2021 | -$22.42M | – |
| FY2020 | Dec 31, 2020 | -$12.70M | – |
| FY2019 | Dec 31, 2019 | -$23.85M | – |
| FY2018 | Dec 31, 2018 | -$5.81M | – |
| FY2017 | Dec 31, 2017 | -$18.88M | – |
| FY2016 | Dec 31, 2016 | -$15.72M | – |
| FY2015 | Dec 31, 2015 | -$21.73K | – |
| FY2014 | Dec 31, 2014 | -$16.02K | – |
| FY2013 | Dec 31, 2013 | -$23.32K | – |
| FY2012 | Dec 31, 2012 | -$24.52K | – |
| FY2011 | Dec 31, 2011 | -$22.77K | – |
| FY2010 | Dec 31, 2010 | -$19.24K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.53M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.21M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$52.96M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.86M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$15.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.16M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.64M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$16.76M | – |
| Q1 FY2023 | Mar 31, 2023 | -$21.31M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.31M | – |
| Q3 FY2022 | Sep 30, 2022 | -$8.20M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.42M | -283.8% |
| Q4 FY2021 | Dec 31, 2021 | -$12.43M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.37M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.19M | -130.9% |
| Q1 FY2021 | Mar 31, 2021 | $10.56M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.28M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.78M | – |
| Q2 FY2020 | Jun 30, 2020 | $10.29M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.94M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.87M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.76M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.15M | -139.2% |
| Q1 FY2019 | Mar 31, 2019 | -$9.08M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.18M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.22M | – |
| Q2 FY2018 | Jun 30, 2018 | $13.11M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.51M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.61M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.32M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.93M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.04M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.83M | – |
See a number that looks wrong?